Company Search:
Advanced Search
Sponsored Links
Cynata Therapeutics Ltd Company Snapshot
Cynata Therapeutics Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cynata Therapeutics Ltd with three other companies in this sector in Australia: Actinogen Medical Ltd (2019 sales of 204,546.00 Australian Dollars [US$139,907.42 ] ), BTC Health Ltd (187,763.00 Australian Dollars [US$128,428.01 ] ), and Botanix Pharmaceuticals Ltd (194,808.00 Australian Dollars [US$133,246.72 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cynata Therapeutics Ltd
  Stock Performance Chart for Cynata Therapeutics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 1.11
(Figures in Australian Dollars)
1 Week -3.1%   13 Weeks -15.0%  
4 Weeks -35.8%   52 Weeks 10.5%  
Cynata Therapeutics Ltd Key Data:
  Ticker: CYP Country: Australia
  Exchanges: Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 194,532
(Year Ending Jan 2020).
Employees: N/A
  Currency: Australian Dollars Market Cap: 112,582,984
  Fiscal Yr Ends: June Shares Outstanding: 101,885,053
  Share Type: Units Closely Held Shares: 23,265,187
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.